A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of
SUVN-G3031 in healthy male subjects following single or multiple ascending doses.